Exchange: NASDAQ·Updated 07:44 PM EST
ICU logo

ICU SeaStar Medical Holding Corp

$0.8919
$0.115
(10.95%)
Today
Closed $0.935
$0.0431
(4.61%)
After Hours
Mkt Cap$4.97M
Vol135,819.00

About ICU

SeaStar Medical Holding Corporation, a commercial-stage healthcare company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis. It also develops NEUTRALIZE-AKI, an SCD therapy that is in clinical trials for adult patients with AKI; and other products in various therapeutic areas, including cardiorenal syndrome, hepatorenal syndrome, and myocardial stunning in end-stage renal disease. SeaStar Medical Holding Corporation was founded in 2007 and is headquartered in Denver, Colorado.
49

Neutral Sentiment

How do you feel about ICU?

SparkyReturns
$ICU I guess some of you have never seen this before - I have: Often, when officers buy shares directly after a drop in share price and before a turnaround in revenue, they will buy shares to show confidence. Its a way of telling us something without telling us something. Its not the amount that matters, its the message. The message is clear: they are seeing something with orders and revenue turning up that they can't disclose yet. Its probably an uptick in orders that is just starting because the SAVE requirements going away was a short time ago. Its going to take a little time for that to have an impact on sales, probably a quarter or two. In the long run, everything will be fine. More than fine. It will be epic. GL longs.
3
5
TribecaTriangle
$ICU $6.1M cash can’t be touched and must stay in cash accounts at all times to meet the $2.5 shareholder’s equity rule to stay listed on Nasdaq. They have around $7M right now so just under $1M useable cash. They need $16M cash between now and end of 2027 while they wait for data. $2M Will come from sales. $14M in dilution. They’re so dumb for not diluting before Sept 31st. The incompetence shows. The exec board is a bunch of idiots, CFO and CEO are lousy. This is my last post. Just watching this stock from very far. Disappointed with the amount of time i spent researching this stock in 2024. I knew not to touch it but the level of incompetence is insane. Can’t imagine what Monday stock trading will look like for icu. Even if investors bought stock, ur going to get buried by dilution. They need to dilute about $3M between now and December 31st. Good luck to you guys. Take care everyone.
3
1
SparkyReturns
$ICU Their Market Cap is so small in comparison to their TAM, that you can't even see it on a linear graph. Revenue is already ramping up, and now that the red tape of SAVE hospital registration is gone, it will ramp up even faster and reduce cash burn until this is turning a profit in either late 2027 or early 2028. The turnaround will be epic.
1
7
SwingTradingPro
$ICU SCD is a live saving miracle device that FDA will approve sooner than later 👍... Just stay invested and you will be credited in due time..
12
Nikki7220
$ICU ***** Longs should not be bothered too much with FUD’s and SP. I will put money where my mouth is = I will double down, tripple down or more under $1. I see everything is good except it’s time for the BOD to vote to remove Eric.
3
5
SparkyReturns
$ICU Dr. Chung bought 7,800 shares with his own money yesterday. They are trying to tell us something.
1
9
ThereturnofiItalianman
$ICU Look, the way we’ve been slapped around repeatedly over the last three years isn’t right, but I’m not selling at a loss. If things really go south for ICU, I’ll just have to accept it and admit it was my own fault. Only invest what you can afford to lose without it turning your life upside down—and, most importantly, if you believe in your investment, give it time. Expect a few stumbles along the way if you’re in it for the long haul... We’ll check back in later, assuming they let us! Adios! 🇮🇹🇱🇷💰🚀🤣🥳😉🐂
12
BULLISH1975
$ICU VIX volatility up huge, SPY and markets down and we having a green day with more than average volume!!! I call that a good day!!!! the SCD saves lives, 7 breakthrough device destinations, TAM billions!!!!! zero side effects, organ ignostic, often prevents dialysis!!!! come on . the entire world needs- deserves this device! no harmful drugs with side effects!!!! patience people❤️❤️❤️ dyor
1
6
Nikki7220
$ICU ***** Some people should think beyond a basic math. Saving life over 65% is NOT 65%. For example of 100 patients, WITHOUT SCD only 30-40% or 30-40 patients. With SCD 65-70 patients. Thats over 90% INCREASE in life saving WITH SCD. FDA is aware of this population statistics. Thats why FDA approved SAVE.
1
8
terrymacarse
$ICU Would be nice if the American govt gave Seastar a grant of $100 or $200 million to progress this to a hopefully successful conclusion rather than spending that money on bombs that make no difference to the lives of Americans
10
Romorton
$ICU Looking at next year's revenue, even under the most conservative estimates, it should reach at least $5.5 million. Furthermore, with clinical trials set to conclude in Q2, R&D expenses will drop sharply in Q3 and Q4—cutting costs by at least $2 million. Top-line data is due for release in September or October; if the results are strong, the stock price will skyrocket. As for concerns about a reverse split or future dilution—honestly, that’s just overthinking it. From now until early Q4 next year—when the data drops—that’s when we’ll know the outcome. Good data means the stock price shoots straight up; bad data means it’s game over. People claiming we’ll need *two* more reverse splits are just trying to scare us retail bulls—I really can't stand people like that.
1
3
OldManLogan
$ICU Weird that they were able to fool those smart folks over at the FDA, you know, the ones that gave the SCD more Breakthrough Device Designations for a single device than any other device in the history of devices, lol. Jury is certainly out on management quality here, but calling the device a scam just makes you look...
9
TribecaTriangle
$ICU this is going to get interesting as people start running through the door to get out here. Problem is they need $5.2M to meet the $2.5M shareholder equity rule. So it means they only have cash of about $2M on hand that’s usable. They need $13M in dilution over the next 12 months on a $5M market cap. 25:1 reverse split coming up. Hope they don’t get permanently delisted off Nasdaq but it will happen if it’s for 30 consecutive days within 1 year of the previous RS. New investors look out. This is dropping to 50 cents, followed by RS and another 50% drop. Big dilutions about to wipe out investors. Don’t tell me you weren’t warned.
2
3
OldManLogan
$ICU If that were even remotely true, why would management give the 'conservative' guidance of $2M in sales for 2026 and thereby intentionally tank the stock? When companies need to rely on equity markets for funding, you do NOT sandbag, if anything you do the opposite. Besides, my initial point was that there's a difference between being long-term bullish about a stock and being unhinged from reality... your $25B in 2030 sales is unhinged and suggests a lack of understanding of the common bottle necks of logistics, scaling, regulation, beaurucratic decision making that stage-gate even compelling products.
2
3
local42r
$ICU winter is here again, the busiest time of the year for icu units in the hospitals. Seastar medical to the rescue. Saving Lives Is their Mission.
6
Jlh50
$ICU The company should be trying to get out there in the mainstream media. The science and saving kids lives is a great story, but most people aren’t aware of it. When Sellas started to look real promising, the ceo was on Fox programs 3 times in a couple of weeks and posts on linked in regularly. They also had webcasts where kols would explain the science for investors. ICU needs an IR or marketing department that needs to be proactive and can do this sort of thing as well as answer emails.
8
nabull
Schlorff's 2021–2025 total reported compensation ($4,290,709) equals SeaStar Medical’s current market capitalization. Schlorff has turned SeaStar Medical ($ICU) into a masterclass in value destruction. Every earnings call brings the same recycled talking points about 'momentum,' while the actual numbers tell a story of chronic failure: a $4.53M quarterly net loss, virtually flat 3% sequential sales growth, and yet another excuse pushing the NEUTRALIZE-AKI trial out to mid-2027. At what point does the board admit that leadership is the primary bottleneck here?
8
sMartMOney24
$ICU I own about 0.26% of SeaStar and I’m not selling a single share. I also know a great guy who owns 4.99%, and he’s not selling either. Let’s get ICU back above $1 next week and start rebuilding confidence!
8
StockJayC
$ICU Such a shame for this company; usual dilution story screwing all investors... The market is just hammering small cap and poor financials at the moment! How long will it last... only the sharks know! Proud to have invested in here and help fund a product that saves lives!
7
Netlinetli
$ICU no, people here dont want instant grayification. they just dont want to lose 90% of their investment while the mgmt is paid insane salaries for not deliver ANYTHING
1
2

Advertisement|Remove ads.